Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Sell

Exponential Moving Average

Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Strong Sell

Wall Street Data Solutions Rating

Neutral

B

BioXcel Therapeutics, Inc. Common Stock (BTAI)

Pharmaceutical Preparations

https://www.bioxceltherapeutics.com

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

555 LONG WHARF DRIVE
NEW HAVEN, CT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

03/08/2018

Market Cap

27,889,131

Shares Outstanding

29,930,000

Weighted SO

29,929,997

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

TERN --.--%

TERN --.--%

AMLX --.--%

AMLX --.--%

ABOS --.--%

INZY --.--%

XFOR --.--%

DAWN --.--%

DAWN --.--%

Beta

0.3180

Last Div

0.0000

Range

0.645-5.62

Chg

0.0045

Avg Vol

653285

Mkt Cap

27889131

Exch

NASDAQ

Country

US

Phone

475 238 6837

DCF Diff

2.1722

DCF

-1.0848

Div Yield

0.0000

P/S

11.6060

EV Multiple

-0.7342

P/FV

-0.3708

Div Yield %

0.0000

P/E

-0.2555

PEG

-0.0102

Payout

0.0000

Current Ratio

2.3520

Quick Ratio

2.2538

Cash Ratio

2.0621

DSO

123.3375

DIO

610.9931

Op Cycle

734.3306

DPO

3022.1362

CCC

-2287.8055

Gross Margin

0.3337

Op Margin

-44.9488

Pretax Margin

-44.8739

Net Margin

-44.8739

Eff Tax Rate

0.0185

ROA

-1.6479

ROE

1.7693

ROCE

-2.8315

NI/EBT

1.0000

EBT/EBIT

0.9983

EBIT/Rev

-44.9488

Debt Ratio

1.5797

D/E

-1.3912

LT Debt/Cap

3.5884

Total Debt/Cap

3.5563

Int Coverage

-7.7185

CF/Debt

-1.0190

Equity Multi

-0.8807

Rec Turnover

2.9594

Pay Turnover

0.1208

Inv Turnover

0.5974

FA Turnover

2.0591

Asset Turnover

0.0367

OCF/Share

-2.6166

FCF/Share

-2.6166

Cash/Share

1.3979

OCF/Sales

-43.8315

FCF/OCF

1.0000

CF Coverage

-1.0190

ST Coverage

-291.7645

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.3708

P/B

-0.3708

P/S

11.6060

P/E

-0.2555

P/FCF

-0.2648

P/OCF

-0.2616

P/CF

-0.2616

PEG

-0.0102

P/S

11.6060

EV Multiple

-0.7342

P/FV

-0.3708

DPS

0.0000

Latest Headlines (EST)

Benzinga Nov 21, 21:47 BioXcel Therapeutics Announces Proposed Public Offering GlobeNewswire Inc. Nov 21, 21:47 BioXcel Therapeutics Announces Proposed Public Offering Benzinga Nov 15, 09:00 Expert Ratings for BioXcel Therapeutics PennyStocks Nov 01, 14:11 5 Most Active Penny Stocks Today & Why They’re Moving Now PennyStocks Oct 31, 14:18 Penny Stocks To Buy Today? 4 To Watch Now PennyStocks Oct 30, 12:09 4 Penny Stocks To Watch Today With Big News, Time To Buy? PennyStocks Oct 26, 15:06 3 Penny Stocks To Buy For Under $5, Are They Worth It? PennyStocks Oct 25, 09:19 5 Hot Penny Stocks To Watch In The Stock Market Today

Revenue Product Segmentation